» Articles » PMID: 28483410

Neoadjuvant Chemotherapy: Survival Benefit in Gastric Cancer

Overview
Journal Lancet Oncol
Specialty Oncology
Date 2017 May 10
PMID 28483410
Citations 47
Authors
Affiliations
Soon will be listed here.
Citing Articles

Efficacy and safety of post-discharge oral nutritional supplements for patients with gastric cancer undergoing gastrectomy: a meta-analysis of randomized controlled trials.

Liang Q, Wang S, Wang B, Hong Y Front Nutr. 2025; 11:1488054.

PMID: 39877540 PMC: 11772097. DOI: 10.3389/fnut.2024.1488054.


Interpretable multi-modal artificial intelligence model for predicting gastric cancer response to neoadjuvant chemotherapy.

Gao P, Xiao Q, Tan H, Song J, Fu Y, Xu J Cell Rep Med. 2024; 5(12):101848.

PMID: 39637859 PMC: 11722130. DOI: 10.1016/j.xcrm.2024.101848.


Peripheral NK cell count predicts response and prognosis in breast cancer patients underwent neoadjuvant chemotherapy.

Zhang C, Wu F, Lu X, Wang S, Wu M, Chen N Front Immunol. 2024; 15:1437193.

PMID: 39403373 PMC: 11471483. DOI: 10.3389/fimmu.2024.1437193.


Case report: pathological complete response after S-1/oxaliplatin regimen combined with trastuzumab and tislelizumab in patients with locally advanced gastric cancer.

Zhu C, Da M, Li Y, Peng L Front Oncol. 2024; 14:1425572.

PMID: 39301541 PMC: 11410570. DOI: 10.3389/fonc.2024.1425572.


Long-term outcomes of laparoscopic versus open total gastrectomy in patients with advanced gastric cancer after neoadjuvant chemotherapy: a retrospective cohort study.

Wang Y, Lei X, Shan F, Li S, Jia Y, Miao R BMC Cancer. 2024; 24(1):1074.

PMID: 39215275 PMC: 11365285. DOI: 10.1186/s12885-024-12669-w.